Anaveon secured CHF 110 million Series B financing led by Forbion and Syncona

Biotech Health services Manufacturing

Investments

16 December 2021

Anaveon (company)

Biotech Health services Manufacturing

Total investments received (USD): 154.34m

Round value (USD): 119.39m

Round investors: Forbion Capital Partners Novartis Venture Fund Pfizer Venture Investments Syncona Pontifax Venture Capital Cowen Healthcare Investments

Company: Anaveon

Industry: Biotech Health services Manufacturing

Biotech Competitive Intelligence Health services Software Services

Investments 13 February 2022

Biotech Competitive Intelligence Health services Software Services

Investments 19 October 2021